Sens. Alsobrooks and Lummis Introduce Bipartisan Bill to Boost Uterine Fibroid Research and Early Detection
This bill is currently being reviewed by the Senate Committee on Health, Education, Labor, and Pensions. The committee recently held hearings to discuss the proposal, which shows it is still actively moving through the process. There are no further actions scheduled at this time.
The bill has support from both parties, which is a strong start. However, it must still pass through committees and compete with other funding priorities to get a full vote.
Uterine fibroids affect fertility and pregnancy outcomes for millions of women. This bill would fund earlier detection through screening and imaging, potentially catching fibroids before they cause complications like infertility, miscarriage, or pregnancy complications. The research into related intrauterine conditions like Asherman's Syndrome also directly benefits women who are trying to become or stay pregnant.
“Screening procedures, including advanced gynecological imaging, including payment for such procedures.”
Committee on Health, Education, Labor, and Pensions. Hearings held.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
No votes have been recorded for this legislation yet.
Document Type
Congressional Bill
Official Title
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
Analysis generated by AI. Always verify with official sources.